Teva Pharmaceutical Industries Ltd - Company Profile
Powered by
All the data and insights you need on Teva Pharmaceutical Industries Ltd in one report.
- Save hours of research time and resources with
our up-to-date Teva Pharmaceutical Industries Ltd Strategy Report
- Understand Teva Pharmaceutical Industries Ltd position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Teva Pharmaceutical Industries Catalyst Calendar
Proactively evaluate Teva Pharmaceutical Industries Ltd’s catalyst impacts to stay ahead of the competition & improve corporate planning. Bolster business development with timely opportunities.
A sample of Teva Pharmaceutical Industries Catalyst Calendar data
Event Date | Event Type | Company Name | Ticker Symbol | Drug Name | Therapy Area | Indication | Source Type |
---|---|---|---|---|---|---|---|
22 Sep 2019 | GDCTWXYZ | Lorem | Lorem | Lorem | WXYZ | Planned | Lorem |
16 Sep 2019 | Constraining Patent Expiry (EU) | Teva Pharmaceutical Industries Ltd | TEVA | Zecuity | Central Nervous System | Migraine | GD Estimates |
09 Sep 2019 | Phase III Trial Completion | ICON Plc; Regeneron Pharmaceuticals Inc; Synexus Clinical Research Ltd; TASK; Teva Pharmaceutical Industries Ltd | ICLR; REGN; TEVA | fasinumab | Central Nervous System; Musculoskeletal Disorders | Osteoarthritis; Osteoarthritis Pain | Clinical Trial Registry |
01 Sep 2019 | Phase II/III Trial Completion | Amgen Inc; AOK Rheinland-Hamburg; Bayer AG; Celgene Corp; F. Hoffmann-La Roche Ltd; Genomic Health Inc; Teva Pharmaceutical Industries Ltd; Westdeutsche Studiengruppe GmbH | AMGN; BAYN; ROG; TEVA | carboplatin; cyclophosphamide; docetaxel; doxorubicin; epirubicin hydrochloride; exemestane; paclitaxel albumin bound; pertuzumab; trastuzumab; trastuzumab emtansine | Oncology | Breast Cancer; Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer (HER2- Breast Cancer); Human Epidermal Growth Factor Receptor 2 Positive Breast Cancer (HER2+ Breast Cancer) | Clinical Trial Registry |
Feature
Catalyst Calendar provides forecasted drug development milestones within the Pharma industry including expected timing, expected outcomes and possible financial impacts.
Benefit
Access:
- Trial Events for trials conducted globally by a company, university, institute or CRO: Trial Initiation, Trial Completion, Trial Results
- Regulatory Events related to drug filings with regulatory bodies, approvals and commercial launches. This is covered for the US, EU and Japan
- Intellectual Property Events for patent and exclusivity expiry specific to the US, EU and Japan: Constraining Patent Expiry (US/EU/Japan), Drug Expiry (US/EU/Japan), Commercial Launch (US/EU/Japan)
Value
Proactively evaluate companies and catalyst impacts
Stay ahead of the competition & improve corporate planning
Bolster business development with timely opportunities
Premium databases is part of our industry range of products
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer